Protein kinase C (PKC) inhibitors were found to restore the impaired cardiac function in diabetes before ischemia; however, PKC inhibitors completely abolished protection against postischemic injury in diabetic hearts [74]. The gene discussed is PRRT2; the disease is diabetes mellitus.